Nitric oxide and cell proliferation

FEBS J. 2006 Jun;273(11):2329-44. doi: 10.1111/j.1742-4658.2006.05250.x.

Abstract

Nitric oxide (NO*) has been proposed to be a physiological modulator of cell proliferation, able to promote in most cases cell cycle arrest. In this review I explore the molecular basis of this mechanism of action. The modulatory action of NO* on the intracellular concentration of cGMP and the machinery directly involved in the control of cell cycle progression, including the expression and activity of diverse cyclins and cyclin-dependent kinases, their physiological inhibitors, and the master transcriptional regulator retinoblastoma protein, will be discussed. The role of NO* in proliferation mediated by tyrosine kinase receptors such as the epidermal growth factor receptor and downstream signalling pathways will also be considered. Finally, the involvement of NO* in proliferative processes relevant for normal development will be outlined.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Cycle / drug effects
  • Cell Cycle / physiology
  • Cell Division / drug effects
  • Cell Division / physiology*
  • Cyclic GMP / physiology
  • Cyclin-Dependent Kinases / physiology
  • Cyclins / physiology
  • Hematopoiesis / drug effects
  • Hematopoiesis / physiology
  • Humans
  • Nitric Oxide / pharmacology
  • Nitric Oxide / physiology*

Substances

  • Cyclins
  • Nitric Oxide
  • Cyclin-Dependent Kinases
  • Cyclic GMP